Dr. Matthew Huentelman conducts Arizona leg of 'Breakthrough
Ride'
PHOENIX, Ariz. - July 29, 2010 - Dr. Matthew Huentelman of the
Translational Genomics Research Institute (TGen) will trade test
tubes and his lab coat today for a safety helmet and shorts as he
bikes 200 miles to help increase funding for Alzheimer's disease
research.
The Breakthrough Ride 2010, sponsored by the national Alzheimer's
Association, started July 17 in San Francisco, Calif., and will end
Sept. 21 - World Alzheimer's Day - in Washington, D.C., in an
effort to encourage Congress to more than quadruple federal funding
for Alzheimer's research.
TGen's Dr. Matthew Huentelman takes off from downtown Phoenix on a
more than 200-mile, three-day bike ride to Holbrook, Ariz., to
support Alzheimer's disease research.
Nearly 60 scientists and researchers are riding relay-style
through 13 states along the 4,500-mile route to show support for
the Alzheimer's Breakthrough Act (S. 1492 & H.R. 3286), which
calls for increased annual funding for Alzheimer's research at the
National Institutes of Health (NIH) to as much as $2 billion, from
$460 million.
According to the Alzheimer's Association, this legislation would
help fund better prevention and treatments for Alzheimer's disease,
which in the long run will save the nation's taxpayers and public
health programs billions of dollars.
According to the Arizona Alzheimer's Consortium - a leading
research collaboration of which TGen is a member - more than 5
million Americans have Alzheimer's, a number projected to grow to
16 million within 30 years.
Dr. Huentelman, an Investigator in TGen's Neurobehavioral Research
Unit, is an avid bike rider who averages about 100 miles a week.
For the Breakthrough Ride, he will start today from Phoenix and
travel more than 200 miles over the next three days, arriving
Saturday in Holbrook, Ariz.
He is joined by two other researchers active in the Arizona
Alzheimer's Consortium in conducting legs of the Breakthrough Ride:
Dr. Michael Sierks of Arizona State University biked from Palm
Springs to Phoenix; and Dr. Lee Ryan of the University of Arizona
will bike from Holbrook to Albuquerque, N.M.
"The Breakthrough Ride is a unique way to raise awareness
regarding the importance of research in the fight against
Alzheimer's by having the actual researchers participate. That
feels especially gratifying," Dr. Huentelman said. "We need to make
Alzheimer's research funding a top priority in this country, as the
socio-economic impact of this disease is already staggering and
only predicted to increase. The devastation of our healthcare
system by this single disorder is possible during our
lifetime."
On this cross-country ride, according to the Alzheimer's
Association, the toughest hill to climb is Capitol Hill. It is
vital to correct the chronic underinvestment in Alzheimer's
research and demand that the federal government create a strategic
national plan to respond to this public health crisis, according to
the association.
Participants in the Breakthrough Ride have established a goal of
collecting 50,000 signatures in support of this new legislation.
More information is available at
www.alz.org/breakthroughride.
*
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. TGen is affiliated
with the Van Andel Research Institute in Grand Rapids, Michigan.
For more information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
# # #